Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells

Transplantation

Volumn 87, Issue 8, 2009, Pages 1134-1139

  Gerner, Michael ^a   Hölig, Kristina ^a   Wehner, Rebekka ^a   Zhao, Senming ^a   Schäkel, Knut ^a   Bachmann, Michael Philipp ^a   Rieber, Ernst Peter ^a   Bornhäuser, Martin ^a   Schmitz, Marc ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Dendritic cells; Extracorporeal photopheresis; Graft versus host disease; T cells

Indexed keywords

6 SULFO N ACETYLLACTOSAMINE; CARBOHYDRATE DERIVATIVE; INTERLEUKIN 12; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 6 SULFO LACNAC; 6-SULFO-LACNAC; AMINOSUGAR; CARRIER PROTEIN; CD31 ANTIGEN; MEMBRANE PROTEIN; PLVAP PROTEIN, HUMAN; PROTEOME; VON WILLEBRAND FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL POLARITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PUVA; T LYMPHOCYTE; TH1 CELL; BLOOD GROUP ABO SYSTEM; IMMUNOBLOTTING; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE;

ABO BLOOD-GROUP SYSTEM; AMINO SUGARS; ANTIGENS, CD31; CARRIER PROTEINS; DENDRITIC CELLS; HUMANS; IMMUNOBLOTTING; INFLAMMATION; MEMBRANE PROTEINS; PHOTOPHERESIS; PROTEOME; VON WILLEBRAND FACTOR;

EID: 65549148114     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819e02d4     Document Type: Article

References (20)

1. Scarisbrick JJ, Taylor P, Holtick U, et al. U.K. consensus statement on the use of extracorporal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008; 158: 659.
2. Greinix HT, Volc-Platzer B, Kahls P, et al. Extracorporal photochemotherapy in the treatment of severe steroid-resistant acute graft-versushost disease: A pilot study. Blood 2000; 96: 2426.
3. Couriel DR, Hosing C, Saliba R, et al. Extracorporal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107: 3074.
4. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767.
5. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419.
6. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graftversus- host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412.
7. Matte CC, Liu J, Cormier J, et al. Donor APCs are required for maximal GvHD but not for GvL. Nat Med 2004; 10: 987.
8. Merad M, Collin M, Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol 2007; 28: 353.
9. Mohty M. Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation. Leuk Lymphoma 2007; 48: 1696.
10. Di Renzo M, Sbano P, De Aloe G, et al. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008; 151: 407.
11. Legitimo A, Consolini R, Failli A, et al. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype. Clin Exp Immunol 2007; 148: 564.
12. Schäkel K, Mayer E, Federle C, et al.Anovel dendritic cell population in human blood: One-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol 1998; 28: 4084.
13. Schäkel K, Kannagi R, Kniep B, et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 2002; 17: 289.
14. Schäkel K, von Kietzell M, Hänsel A, et al. Human 6-sulfo LacNAcexpressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 2006; 24: 767.
15. Baumeister SH, Hölig K, Bornhäuser M, et al. G-CSF mobilizes slan- DCs (6-sulfo LacNAc- dendritic cells) with a high proinflammatory capacity. Blood 2007; 110: 3078.
16. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139.
17. Ferrara JLM. Novel strategies for the treatment and diagnosis of graftversus- host-disease. Best Pract Res Clin Haematol 2007; 20: 91.
18. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340.
19. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46: 55.
20. Holtick U, Marshall SR,WangX, et al. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocytederived dendritic cells. Transplantation 2008; 85: 757.